| MDCO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MDCO shares outstanding history going back to 3/10/2010:
Also see: MDCO Market Cap History MDCO YTD Return |
As of 10/28/2019 Medicines has 79.72 million MDCO shares outstanding. Investors often track the MDCO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows MDCO share count trends over time, with 41 historical shares outstanding datapoints presented, dating back to 3/10/2010.

| MDCO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MDCO shares outstanding history going back to 3/10/2010:
Also see: MDCO Market Cap History MDCO YTD Return |
| MDCO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MDCO Historical Shares Outstanding: +4.33% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MDCO Stock Price Chart |
| About Medicines Co (The) |
| Medicines is a biopharmaceutical company. Co. is focused on inclisiran, the investigational RNA interference therapeutic, that inhibits production of proprotein convertase subtilisin/kexin type 9, a main protein that controls low-density lipoprotein-cholesterol levels. Co. has the right to develop, manufacture and commercialize inclisiran under its collaboration agreement with Alnylam Pharmaceuticals, Inc. We show 41 historical shares outstanding datapoints in our coverage of MDCO's shares outstanding history. Understanding the changing numbers of MDCO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MDCO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MDCO by allowing them to research MDCO shares outstanding history as well as any other stock in our coverage universe. |
| MDCO Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| MDCO Share Performance |
| Shares Outstanding Peers |
| Medicines (MDCO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MDGL Shares Outstanding History MDT Shares Outstanding History MDXG Shares Outstanding History ME Shares Outstanding History MEDP Shares Outstanding History MEIP Shares Outstanding History MGEN Shares Outstanding History MGLN Shares Outstanding History MGNX Shares Outstanding History MGRM Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.